|
C12ORF48 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.559000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.623000E-01 |
| Normal-vs-Stage2 |
4.471700E-02 |
| Normal-vs-Stage3 |
3.582100E-02 |
| Normal-vs-Stage4 |
3.877300E-03 |
| Stage1-vs-Stage2 |
8.479900E-02 |
| Stage1-vs-Stage3 |
7.661900E-02 |
| Stage1-vs-Stage4 |
6.975300E-03 |
| Stage2-vs-Stage3 |
6.271400E-01 |
| Stage2-vs-Stage4 |
1.867400E-01 |
| Stage3-vs-Stage4 |
7.238300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.683300E-03 |
| Normal-vs-AfricanAmerican |
8.117800E-01 |
| Normal-vs-Asian |
3.089200E-01 |
| Caucasian-vs-AfricanAmerican |
1.215550E-02 |
| Caucasian-vs-Asian |
7.745400E-01 |
| AfricanAmerican-vs-Asian |
3.403800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.557500E-04 |
| Normal-vs-Female |
3.652000E-01 |
| Male-vs-Female |
2.804500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.182100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.101510E-02 |
| Normal-vs-Age(61-80Yrs) |
2.792000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.597000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.644000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.058000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.292300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.592600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.009900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.230240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.229800E-01 |
| Normal-vs-Grade 2 |
1.860850E-01 |
| Normal-vs-Grade 3 |
3.712200E-02 |
| Normal-vs-Grade 4 |
4.385000E-03 |
| Grade 1-vs-Grade 2 |
1.396190E-02 |
| Grade 1-vs-Grade 3 |
1.664200E-03 |
| Grade 1-vs-Grade 4 |
1.497730E-03 |
| Grade 2-vs-Grade 3 |
3.427000E-01 |
| Grade 2-vs-Grade 4 |
1.324090E-02 |
| Grade 3-vs-Grade 4 |
2.802400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.680800E-01 |
| Normal-vs-ccB subtype |
2.805900E-04 |
| ccA subtype-vs-ccB subtype |
1.77069999999224E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.524800E-03 |
| Normal-vs-N1 |
3.023800E-03 |
| N0-vs-N1 |
5.940000E-03 |
|
|
